Versão em português


FAPESP, Fundação Biominas and GlaxoSmithKline Brasil (GSK) signed an agreement to develop a programme whereby selected research institutions from the State of São Paulo will receive funding and in-kind support to conduct scientific research activities in the areas of respiratory, immuno-inflammation, immuno-oncology, and human immunodeficiency virus (HIV).

Cooperation agreement - Signed on July 31, 2018, with a validity of five years.

Call for proposals: